Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial — Professor Gregory Lip (2020) | RDL Network
Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial
Male gender, higher mean weight and higher mean BMI were associated with unsuccessful cardioversion. Efficacy and safety outcomes were low and did not differ by cardioversion success.
Andreas Goette, Joris R. de Groot, Jean‐Yves Le Heuzey, Maciej Banach, Kurt Huber, James Jin, Michael Melino, Shannon M. Winters, Sakis Themistoclakis, Professor Gregory Lip
Andreas Goette, José Luís Merino, Raffaele De Caterina, Kurt Huber, Hein Heidbüchel, James Jin, Michael Melino, Shannon M. Winters, Professor Gregory Lip
Andreas Goette, José Luís Merino, Michael D. Ezekowitz, Dmitry Zamoryakhin, Michael Melino, James Jin, Michele Mercuri, Michael Grosso, Víctor Fernández, Naab Al‐Saady, Natalya Pelekh, Béla Merkely, Sergey Zenin, Mykola Kushnir, Jindřich Špinar, Valeriy Batushkin, Joris R. de Groot, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.